Class II
Terminated
Adenosine Injection in all strengths, all doses, and all packaging.
Why: Lack of sterility assurance.
- Company
- Pharmedium Services, LLC
Lake Forest, IL, United States - Reported
- Feb 28, 2018
- Recall started
- Dec 27, 2017
- Ended
- May 7, 2020
- Where sold
- U.S.A. Nationwide
- Amount
- Unknown
- Full product description
- Adenosine Injection in all strengths, all doses, and all packaging.
- Lots / codes affected
- All lots remaining within expiry.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.